The COVAX Advanced Market Commitment has an initial target of $2
billion to buy the vaccines.
"Up to today, what has been mobilised so far is $700 million ... So
there is a great deal of work to be done to diversify the possible
sources of funding," Matshidiso Moeti, Africa regional director for
the WHO, told an online press briefing.
COVAX is co-led by the GAVI Vaccine Alliance, the WHO and the CEPI
Coalition for Epidemic Preparedness Innovations. Its aim is to
deliver 2 billion doses of effective, approved COVID-19 vaccines by
the end of 2021.
[to top of second column] |
At least eight African countries, including South Africa, Gabon, Namibia and
Equatorial Guinea had agreed to self-finance access to the vaccine, Moeti said.
The Africa Centres for Disease Control and Prevention said last month the
continent had started to slowly "bend the curve" of COVID-19 infections as
measures like mask-wearing and social distancing slow the spread of the
pandemic.
(Reporting by MacDonald Dzirutwe; Editing by Frances Kerry)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |